Jonathan Scott Hurd - 18 Mar 2026 Form 4 Insider Report for INTELLIGENT BIO SOLUTIONS INC. (INBS)

Reporting relationship: Director
Issuer ticker: INBS
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Mar 2026, 17:00:31 UTC
Prior SEC filing: 12 Oct 2022
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Scott Hurd

Key filing fact

Jonathan Scott Hurd filed Form 4 for INTELLIGENT BIO SOLUTIONS INC. (INBS) on 20 Mar 2026.

Key facts

This page summarizes Jonathan Scott Hurd's Form 4 filing for INTELLIGENT BIO SOLUTIONS INC. (INBS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 Mar 2026, 17:00.

Change

Previous filing in this sequence was filed on 12 Oct 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001830112 Primary reporting owner

Hurd Jonathan Scott

Relationship: Director
Address: C/O INTELLIGENT BIO SOLUTIONS INC.,, 135 WEST 41ST STREET, 5TH FLOOR, NEW YORK
Signature: /s/ Jonathan Scott Hurd
Signature date: 19 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INBS transaction

Common Stock

Award

Transaction value
Shares: +5,000
Change %: +83333%
Price: $0.000000^*
Shares after: 5,006
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On December 15, 2025, Intelligent Bio Solutions Inc. (the "Issuer") effected a 1-for-10 reverse stock split of the Issuer's common stock ("Common Stock"). The reverse stock split effected in December 2025, and prior reverse stock splits effected by the Issuer, resulted in a reduction in the number of shares held by the reporting person and proportional adjustments to the outstanding equity awards held by the reporting person. Accordingly, all amounts in this Form 4 are presented on a post-reverse split basis.

Footnote F2

On March 18, 2026, the Issuer granted the reporting person 5,000 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The awarded shares are subject to time-based vesting after 12 months and are subject to forfeiture until vested.